Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy.

Hage C, Hoves S, Ashoff M, Schandl V, Hört S, Rieder N, Heichinger C, Berrera M, Ries CH, Kiessling F, Pöschinger T.

PLoS One. 2019 Jul 10;14(7):e0219517. doi: 10.1371/journal.pone.0219517. eCollection 2019.

2.

Direct and indirect effects of land use on bryophytes in grasslands.

Boch S, Allan E, Humbert JY, Kurtogullari Y, Lessard-Therrien M, Müller J, Prati D, Rieder NS, Arlettaz R, Fischer M.

Sci Total Environ. 2018 Dec 10;644:60-67. doi: 10.1016/j.scitotenv.2018.06.323. Epub 2018 Jul 4.

PMID:
29980086
3.

Thymidine Metabolism as a Confounding Factor for 3'-Deoxy-3'-18F-Fluorothymidine Uptake After Therapy in a Colorectal Cancer Model.

Schelhaas S, Wachsmuth L, Hermann S, Rieder N, Heller A, Heinzmann K, Honess DJ, Smith DM, Fricke IB, Just N, Doblas S, Sinkus R, Döring C, Schäfers KP, Griffiths JR, Faber C, Schneider R, Aboagye EO, Jacobs AH.

J Nucl Med. 2018 Jul;59(7):1063-1069. doi: 10.2967/jnumed.117.206250. Epub 2018 Feb 23.

4.

A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.

Kollmorgen G, Palme K, Seidl A, Scheiblich S, Birzele F, Wilson S, Clemens C, Voss E, Kaufmann M, Hirzel K, Rieder N, Krippendorff BF, Herting F, Niederfellner G.

Sci Rep. 2017 Dec 22;7(1):18086. doi: 10.1038/s41598-017-17329-7.

5.

Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.

Nguyen F, Peña L, Ibisch C, Loussouarn D, Gama A, Rieder N, Belousov A, Campone M, Abadie J.

Breast Cancer Res Treat. 2018 Feb;167(3):635-648. doi: 10.1007/s10549-017-4548-2. Epub 2017 Oct 30.

6.

Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.

Abadie J, Nguyen F, Loussouarn D, Peña L, Gama A, Rieder N, Belousov A, Bemelmans I, Jaillardon L, Ibisch C, Campone M.

Breast Cancer Res Treat. 2018 Jan;167(2):459-468. doi: 10.1007/s10549-017-4542-8. Epub 2017 Oct 23.

7.

XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer.

Schanzer JM, Wartha K, Moessner E, Hosse RJ, Moser S, Croasdale R, Trochanowska H, Shao C, Wang P, Shi L, Weinzierl T, Rieder N, Bacac M, Ries CH, Kettenberger H, Schlothauer T, Friess T, Umana P, Klein C.

MAbs. 2016 May-Jun;8(4):811-27. doi: 10.1080/19420862.2016.1160989. Epub 2016 Mar 16.

8.

Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA).

Bader S, Zajac M, Friess T, Ruge E, Rieder N, Gierke B, Heubach Y, Thomas M, Pawlak M.

Mol Cell Proteomics. 2015 Oct;14(10):2775-85. doi: 10.1074/mcp.O114.045542. Epub 2015 Jun 23.

9.

Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma.

Herting F, Friess T, Bader S, Muth G, Hölzlwimmer G, Rieder N, Umana P, Klein C.

Leuk Lymphoma. 2014 Sep;55(9):2151-5160. doi: 10.3109/10428194.2013.856008. Epub 2014 Feb 4.

10.

Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.

Kollmorgen G, Niederfellner G, Lifke A, Spohn GJ, Rieder N, Harring SV, Bauss F, Burtscher H, Lammers R, Bossenmaier B.

Mol Oncol. 2013 Dec;7(6):1142-51. doi: 10.1016/j.molonc.2013.08.009. Epub 2013 Sep 3.

11.

Increased consistency and efficiency in routine potency testing by bioassay with direct use of cryopreserved (ready-to-plate) cells.

TerWee JA, Chin CL, Watrin S, Tello RF, Rieder NJ, Lowell JD, Latham-Timmons D.

J Immunol Methods. 2011 Jul 29;370(1-2):65-74. doi: 10.1016/j.jim.2011.05.009. Epub 2011 Jun 12.

PMID:
21664360
12.

Influence of accelerations on the spatial orientation of Loxodes and Paramecium.

Hemmersbach R, Voormanns R, Briegleb W, Rieder N, Häder DP.

J Biotechnol. 1996 Jun 27;47(2-3):271-8.

PMID:
11536765
13.

Cutaneous myiasis: review of 13 cases in travelers returning from tropical countries.

Jelinek T, Nothdurft HD, Rieder N, Löscher T.

Int J Dermatol. 1995 Sep;34(9):624-6.

PMID:
7591459
14.
15.

[Eimeria leuckarti infections in foals and their mothers in upper Bavaria].

Beelitz P, Rieder N, Gothe R.

Tierarztl Prax. 1994 Aug;22(4):377-81. German.

PMID:
7940517
16.

[Fall/winter depression and its therapy].

Neumeister A, Kapitany T, Rieder N, Kasper S.

Wien Klin Wochenschr. 1994;106(21):665-70. Review. German.

PMID:
7810151
17.

[Personality profile in bipolar schizoaffective psychoses. A comparison with bipolar affective psychoses].

Thau K, Lenz G, Rieder N, Kubinger K, Grisar E.

Nervenarzt. 1991 Nov;62(11):682-8. German.

PMID:
1770968
18.

[Ultrastructure of the carapax cuticle of Triops cancriformis Bosc. (Notostraca, Crustacea)].

Rieder N.

Z Naturforsch B. 1972 May;27(5):579. German. No abstract available.

PMID:
4403415
20.

Two innate releasing mechanisms subserving the same motor pattern system.

Curio E, Blaich R, Rieder N.

Nature. 1970 Feb 21;225(5234):750-1. No abstract available.

PMID:
16056723
21.

[Early stages of toxicyst development in Didinium nasutum].

Rieder N.

Z Naturforsch B. 1968 Apr;23(4):569. German. No abstract available.

PMID:
4386062
22.

[Electron microscope studies on the resting structure of the toxicysts of Didinium nasutum].

Rieder N.

Z Naturforsch B. 1968 Apr;23(4):569. German. No abstract available.

PMID:
4386061

Supplemental Content

Loading ...
Support Center